# Endothelial Cell Activation and Total Pulmonary Resistance in PAH

> **NCT06035861** · NA · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 6 (estimated)

## Conditions studied

- Pulmonary Artery Hypertension

## Interventions

- **DRUG:** XBD173

## Key facts

- **NCT ID:** NCT06035861
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06035861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06035861, "Endothelial Cell Activation and Total Pulmonary Resistance in PAH". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06035861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*